Grave ethical allegations hound India’s homegrown Covid-19 vaccine as it prepares for rollout
Bharat Biotech began to pay homage to controversy when scientists raised concerns about Covaxin's hasty approval. Some participants say they were not informed that they were part of a clinical trial.
Last News
Why Biden’s Ambitious Covid Relief Plan Could Get Cut in Half
3 reasons why the DJ LeMahieu deal is a steal for the Yankees
‘Acasa, My Home’ Review: An Immersive and Often Brutal Window Into Life on the Romanian Margins
Mets avoid arb with 7 players, including Lindor, Conforto
China urged to tap RCEP trade deal for future digital payments system as US sanctions loom